Abstract
Comprehensively understanding cancer biology requires complex model systems, typically animal models, to replicate tumor behavior, microenvironment interactions, and cell migration/metastatic processes. Traditionally, genetically engineered and xenograft mouse models have been the cornerstone of cancer research. In recent years, the 3R principle—Replacement, Reduction, and Refinement—has reshaped ethical cancer research by promoting alternative animal models. Here we critically examine in vitro and in silico as well as four 3R-compliant animal models — the chicken chorioallantoic membrane (CAM) model, Danio rerio, Drosophila melanogaster, and Caenorhabditis elegans — and assess their advantages, limitations, and translational relevance for cancer research. Special emphasis is placed on practical considerations to inform optimal decision-making, including reproducibility and model-specific advantages and challenges. This review aims to support researchers in selecting ethical and effective preclinical models to advance cancer research.
